Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
297/2019
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2019/336 frá 27. febrúar 2019 um breytingu á reglugerð (ESB) nr. 1141/2010 og framkvæmdarreglugerð (ESB) nr. 686/2012 að því er varðar skýrslugjafaraðildarríki til að meta 1-metýlsýklóprópen, famoxadón, mankóseb, metíókarb, metoxýfenósíð, pírimíkarb, pírimífosmetýl og þíaklópríð
Durchführungsverordnung (EU) 2019/336 der Kommission vom 27. Februar 2019 zur Änderung der Verordnung (EU) Nr. 1141/2010 und der Durchführungsverordnung (EU) Nr. 686/2012 hinsichtlich des berichterstattenden Mitgliedstaats für die Bewertung von 1-Methylcyclopropen' Famoxadon, Mancozeb, Methiocarb, Methoxyfenozid, Pirimicarb, Pirimiphos-Methyl und Thiacloprid
Kommisjonens gjennomføringsforordning (EU) 2019/336 av 27. februar 2019 om endring av forordning (EU) nr. 1141/2010 og gjennomføringsforordning (EU) nr. 686/2012 med hensyn til rapporterende medlemsstat for vurdering av 1-metylsyklopropen, famoksadon, mankozeb, metiokarb, metoksyfenozid, pirimikarb, pirimifos-metyl og tiakloprid
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.